176 related articles for article (PubMed ID: 32940907)
1. Lowering the transmission and spread of human coronavirus.
Meyers C; Robison R; Milici J; Alam S; Quillen D; Goldenberg D; Kass R
J Med Virol; 2021 Mar; 93(3):1605-1612. PubMed ID: 32940907
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
[TBL] [Abstract][Full Text] [Related]
3. Effective
Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of various gargle formulations and salt water against SARS-CoV-2.
Tiong V; Hassandarvish P; Bakar SA; Mohamed NA; Wan Sulaiman WS; Baharom N; Abdul Samad FN; Isahak I
Sci Rep; 2021 Oct; 11(1):20502. PubMed ID: 34654867
[TBL] [Abstract][Full Text] [Related]
6. Virucidal activity of a plant-oil-based oral rinse against respiratory viruses.
Meister TL; Brüggemann Y; Becker B; Paulmann D; Brill FHH; Steinmann E
J Hosp Infect; 2024 May; 147():83-86. PubMed ID: 38490488
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of germicidal ultraviolet light to inactivate coronaviruses on personal protective equipment to reduce nosocomial transmission.
Camargo C; Lupien A; McIntosh F; Menzies D; Behr MA; Sagan SM
Infect Control Hosp Epidemiol; 2022 Jul; 43(7):886-891. PubMed ID: 34154679
[TBL] [Abstract][Full Text] [Related]
8. Oral antiseptics against coronavirus: in-vitro and clinical evidence.
Mateos-Moreno MV; Mira A; Ausina-Márquez V; Ferrer MD
J Hosp Infect; 2021 Jul; 113():30-43. PubMed ID: 33865974
[TBL] [Abstract][Full Text] [Related]
9. Viral Inactivation with Emphasis on SARS-CoV-2 Using Physical and Chemical Disinfectants.
Fadaei A
ScientificWorldJournal; 2021; 2021():9342748. PubMed ID: 34712107
[TBL] [Abstract][Full Text] [Related]
10. Ethanol and isopropanol inactivation of human coronavirus on hard surfaces.
Meyers C; Kass R; Goldenberg D; Milici J; Alam S; Robison R
J Hosp Infect; 2021 Jan; 107():45-49. PubMed ID: 32991941
[TBL] [Abstract][Full Text] [Related]
11. In vitro virucidal activity of mouthwashes on SARS-CoV-2.
Buonavoglia A; Lanave G; Marchi S; Lorusso P; Montomoli E; Martella V; Camero M; Prati C; Trombetta CM
Oral Dis; 2022 Nov; 28 Suppl 2():2509-2515. PubMed ID: 35398970
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2.
Ferrer MD; Barrueco ÁS; Martinez-Beneyto Y; Mateos-Moreno MV; Ausina-Márquez V; García-Vázquez E; Puche-Torres M; Giner MJF; González AC; Coello JMS; Rueda IA; Aubá JMV; Español CC; Velasco AL; Abad DS; García-Esteban S; Artacho A; López-Labrador X; Mira A
Sci Rep; 2021 Dec; 11(1):24392. PubMed ID: 34937855
[TBL] [Abstract][Full Text] [Related]
13. Do hydrogen peroxide mouthwashes have a virucidal effect? A systematic review.
Ortega KL; Rech BO; El Haje GLC; Gallo CB; Pérez-Sayáns M; Braz-Silva PH
J Hosp Infect; 2020 Dec; 106(4):657-662. PubMed ID: 33058941
[TBL] [Abstract][Full Text] [Related]
14. Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase?
Landi F; Marzetti E; Sanguinetti M; Ciciarello F; Tritto M; Benvenuto F; Bramato G; Brandi V; Carfì A; D'Angelo E; Fusco D; Lo Monaco MR; Martone AM; Pagano F; Rocchi S; Rota E; Russo A; Salerno A; Cattani P; Marchetti S; Bernabei On Behalf Of The Gemelli Against Covid-Geriatric Team R
Trans R Soc Trop Med Hyg; 2021 Jan; 115(1):74-77. PubMed ID: 32948871
[TBL] [Abstract][Full Text] [Related]
15. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
Khan MM; Parab SR; Paranjape M
Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
[TBL] [Abstract][Full Text] [Related]
17. Virucidal activity in vitro of mouthwashes against a feline coronavirus type II.
Buonavoglia A; Camero M; Lanave G; Catella C; Trombetta CM; Gandolfi MG; Palazzo G; Martella V; Prati C
Oral Dis; 2022 Nov; 28 Suppl 2(Suppl 2):2492-2499. PubMed ID: 34739171
[TBL] [Abstract][Full Text] [Related]
18. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses.
Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
J Prosthodont; 2020 Aug; 29(7):599-603. PubMed ID: 32608097
[TBL] [Abstract][Full Text] [Related]
19. Review of the use of nasal and oral antiseptics during a global pandemic.
Stathis C; Victoria N; Loomis K; Nguyen SA; Eggers M; Septimus E; Safdar N
Future Microbiol; 2021 Jan; 16(2):119-130. PubMed ID: 33464122
[TBL] [Abstract][Full Text] [Related]
20. Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial.
Carrouel F; Valette M; Gadea E; Esparcieux A; Illes G; Langlois ME; Perrier H; Dussart C; Tramini P; Ribaud M; Bouscambert-Duchamp M; Bourgeois D
Clin Microbiol Infect; 2021 Oct; 27(10):1494-1501. PubMed ID: 34044151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
